Feline Infectious Peritonitis (FIP) was once virtually universally fatal, but antiviral treatments now offer cure rates exceeding 85% in many cats.
FIP causes severe suffering through fluid accumulation, neurological damage, and systemic inflammation. The emergence of effective antiviral treatments represents one of the most significant welfare advances in feline medicine. However, access barriers including cost and licensing issues mean many cats still do not receive curative treatment.